Active Not RecruitingNCT06269146
Pramipexole to Enhance Social Connections
Medication studyAges 18–50United StatesAnxiety
Understand this study
Who could participate?
Listed age limits: 18 years to 50 years.
- Listed locations
- San Diego and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 13, 2024
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 108
- Sponsor
- University of California, San Diego
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT06269146
- Official title
Show the full official title
Targeting Dopamine-Mediated Social Reward Sensitivity to Remediate Social Disconnection
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Diego · New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, San Diego, a university.
Does this study involve medication?
Yes. The study involves medication, including Pramipexole Pill and Placebo Pill.
Who can participate?
Listed age limits: 18 years to 50 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
